Cabergoline in infertile women with peritoneal endometriosis

Phase 4, randomised, double-blind trial in endometriosis and female infertility comparing Cabergoline (Dostinex) with Placebo (2 arms). Primary endpoints: Change in worst Numeric Rating Scale (NRS) of menstrual pain, weekly pelvic pain, and pain during intercourse and Proportion of subjects with clinically meaningful pain reduction. Planned start Dec 2022; status: withdrawn.